Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LIFECORE BIOMEDICAL, INC. \DE\
Report date October 14, 2020 · Filed October 15, 2020
Section 16 reporting ended · disclosed 2020-10-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectIn Trust | 74,327 |
Reported balance
After 2020-10-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-10-14 · Grant · Acquired 8,303 · Balance 74,327 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Common StockSEC Table I · non-derivative | IndirectIn Trust | 76,527 |
Reported balance
After 2020-10-14 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2020-10-14 · Grant · Acquired 2,200 · Balance 76,527 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-10-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-10-14 · Exercise / conversion · Disposed 2,200 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on October 14, 2019. F3: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-10-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-10-14 · Exercise / conversion · Disposed 8,303 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4: The restricted stock units were granted on June 1, 2020. F3: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on October 14, 2019.
F3: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors.
F4: The restricted stock units were granted on June 1, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 14, 2020 Filed Oct 15, 2020 22:55 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 8,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-002036 · primary_01.xml · derivative · entry 4 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,303 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4 · shares: The restricted stock units were granted on June 1, 2020. F3 · derivative.exercise_date: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors. F3 · derivative.expiration_date: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 22:55 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-002036 · primary_01.xml · derivative · entry 3 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on October 14, 2019. F3 · derivative.exercise_date: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors. F3 · derivative.expiration_date: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 22:55 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 2,200 | $10.42 | $22,924.00 |
DisclosureSEC source: 0001593968-20-002036 · primary_01.xml · nonDerivative · entry 2 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust Disclosed balance after: 76,527 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 22:55 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 8,303 | $10.42 | $86,517.26 |
DisclosureSEC source: 0001593968-20-002036 · primary_01.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust Disclosed balance after: 74,327 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 22:25 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 8,303 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-008850 · wf-form4_159113669840840.xml · derivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust Disclosed balance after: 8,303 Underlying: Common Stock · 8,303 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 28, 2020 Filed May 29, 2020 19:50 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-008624 · wf-form4_159078182752435.xml · derivative · entry 2 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2020-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28, 2019. F3 · derivative.exercise_date: The restricted stock units vested on May 28, 2020. F3 · derivative.expiration_date: The restricted stock units vested on May 28, 2020. Read SEC document |
| May 28, 2020 Filed May 29, 2020 19:50 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 6,000 | $10.99 | $65,940.00 |
DisclosureSEC source: 0001628280-20-008624 · wf-form4_159078182752435.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 66,024 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 19:16 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 2,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-012372 · wf-form4_157133972786200.xml · derivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · In trust Disclosed balance after: 2,200 Underlying: Common Stock · 2,200 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 30, 2019 Filed May 31, 2019 00:38 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007411 · wf-form4_155926307105581.xml · derivative · entry 2 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust Disclosed balance after: 0 Underlying: Common Stock · 4,240 shares Expires 2019-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 30, 2018. F3 · derivative.exercise_date: The restricted stock units vested on May 30, 2019. F3 · derivative.expiration_date: The restricted stock units vested on May 30, 2019. Read SEC document |
| May 30, 2019 Filed May 31, 2019 00:38 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,240 | $9.91 | $42,018.40 |
DisclosureSEC source: 0001628280-19-007411 · wf-form4_155926307105581.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 60,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 28, 2019 Filed May 31, 2019 00:38 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Units (RSU) · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-007411 · wf-form4_155926307105581.xml · derivative · entry 3 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| April 29, 2019 Filed Apr 30, 2019 18:32 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0001628280-19-005156 · wf-form4_155664914749416.xml · derivative · entry 3 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2019 Filed Apr 30, 2019 18:32 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 3,217 | $10.35 | $33,295.95 |
DisclosureSEC source: 0001628280-19-005156 · wf-form4_155664914749416.xml · nonDerivative · entry 2 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 55,784 Read SEC document |
| April 29, 2019 Filed Apr 30, 2019 18:32 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $6.66 | $33,300.00 |
DisclosureSEC source: 0001628280-19-005156 · wf-form4_155664914749416.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 59,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 21:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-011101 · rdgdoc.xml · derivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 4,240 Underlying: Common Stock · 4,240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010774 · rdgdoc.xml · derivative · entry 2 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held In trust Disclosed balance after: 0 Underlying: Common Stock · 4,286 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2017. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,286 | $13.65 | $58,503.90 |
DisclosureSEC source: 0001437749-18-010774 · rdgdoc.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 54,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:07 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.77 | $0.00 |
DisclosureSEC source: 0001437749-18-004232 · rdgdoc.xml · derivative · entry 3 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:07 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,177 | $13.25 | $28,845.25 |
DisclosureSEC source: 0001437749-18-004232 · rdgdoc.xml · nonDerivative · entry 2 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 49,715 Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 23:07 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $5.77 | $28,850.00 |
DisclosureSEC source: 0001437749-18-004232 · rdgdoc.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 51,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 23:19 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-010670 · rdgdoc.xml · derivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,286 Underlying: Common Stock · 4,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 25, 2017 Filed May 26, 2017 22:56 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-010190 · rdgdoc.xml · derivative · entry 2 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held In trust Disclosed balance after: 0 Underlying: Common Stock · 5,282 shares Expires 2017-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 25, 2016. F3 · derivative.exercise_date: The restricted stock units vested on May 25, 2017. F3 · derivative.expiration_date: The restricted stock units vested on May 25, 2017. Read SEC document |
| May 25, 2017 Filed May 26, 2017 22:56 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,282 | $13.50 | $71,307.00 |
DisclosureSEC source: 0001437749-17-010190 · rdgdoc.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 46,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| April 11, 2017 Filed Apr 12, 2017 18:34 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 3,025 | $14.00 | $42,350.00 |
DisclosureSEC source: 0001437749-17-006497 · rdgdoc.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 41,610 Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:46 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001437749-17-006403 · rdgdoc.xml · derivative · entry 3 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2017-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:46 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 1,975 | $14.25 | $28,143.75 |
DisclosureSEC source: 0001437749-17-006403 · rdgdoc.xml · nonDerivative · entry 2 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 44,635 Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:46 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $5.63 | $28,150.00 |
DisclosureSEC source: 0001437749-17-006403 · rdgdoc.xml · nonDerivative · entry 1 FRANK FRED · CIK 0001181155 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held By Trust Disclosed balance after: 46,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.